CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | Robb Gary Charles Chief Business Officer | Gift | +639 | 8,700 | ||
| 2023-12-08 | Robb Gary Charles Chief Business Officer | Gift | +639 | 8,700 | ||
| 2023-12-06 | Robb Gary Charles Chief Business Officer | Sale | −6,212 | $27.01 | $168K | 21,390 |
| 2023-12-05 | Robb Gary Charles Chief Business Officer | Sale | −1,381 | $26.27 | $36K | 27,602 |
| 2023-12-04 | Robb Gary Charles Chief Business Officer | Option exercise | +15,000 | $3.29 | $49K | 37,771 |
| 2023-12-04 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −8,788 | $26.26 | $231K | 28,983 |
| 2023-12-04 | Robb Gary Charles Chief Business Officer | Option exercise · Stock option (right to buy) | −15,000 | 61,037 | ||
| 2023-12-04 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise 10b5-1 | +2,432 | $11.35 | $28K | 8,286 |
| 2023-12-04 | Lyon Joseph Douglas Chief Accounting Officer | Sale 10b5-1 | −2,432 | $26.00 | $63K | 5,854 |
| 2023-12-01 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $5.86 | $13K | 2,200 |
| 2023-12-01 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $25.47 | $56K | 0 |
| 2023-12-01 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 15,550 | ||
| 2023-12-01 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise 10b5-1 | +2,568 | $11.35 | $29K | 8,422 |
| 2023-12-01 | Lyon Joseph Douglas Chief Accounting Officer | Sale 10b5-1 | −2,568 | $26.00 | $67K | 5,854 |
| 2023-12-01 | Lyon Joseph Douglas Chief Accounting Officer | Grant or award 10b5-1 | +460 | $25.97 | $12K | 6,314 |
| 2023-12-01 | Lyon Joseph Douglas Chief Accounting Officer | Grant or award 10b5-1 | +460 | 6,774 | ||
| 2023-12-01 | Lyon Joseph Douglas Chief Accounting Officer | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 44,167 | ||
| 2023-12-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +10,009 | $2.61 | $26K | 83,300 |
| 2023-12-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +14,991 | $3.29 | $49K | 98,291 |
| 2023-12-01 | Maduck Sean See Remarks | Sale 10b5-1 | −25,000 | $25.56 | $639K | 73,291 |
Page 44 of 61 · 1,220 trades